Table 4. The association between ultrasonographic, clinicopathologic and genomic characteristics on the RFS and overall survival of all TNBC patients (N=109).
| Variables | RFS | Death | |||||
|---|---|---|---|---|---|---|---|
| Yes | No | P | Yes | No | P | ||
| Tumor size (cm) | 0.339 | 0.198 | |||||
| ≤2 cm | 6 (14.0) | 37 (86.0) | 3 (7.0) | 40 (93.0) | |||
| >2 cm | 14 (21.2) | 52 (78.8) | 10 (15.2) | 56 (84.8) | |||
| US features group | 0.363 | 0.207 | |||||
| Group 1 | 3 (10) | 27 (90) | 1 (3.3) | 29 (96.7) | |||
| Group 2 | 14 (22.2) | 49 (77.8) | 9 (14.3) | 54 (85.7) | |||
| Group 3 | 3 (18.9) | 13 (81.3) | 3 (18.8) | 13 (81.3) | |||
| LNM | 0.001* | 0.007* | |||||
| Yes | 12 (37.5) | 20 (62.5) | 8 (25) | 24 (75) | |||
| No | 8 (10.4) | 69 (89.6) | 5 (6.5) | 72 (93.5) | |||
| Radiotherapy | 0.019* | 0.001* | |||||
| Yes | 10 (34.5) | 19 (65.5) | 9 (31.0) | 20 (69.0) | |||
| No | 10 (14.1) | 61 (85.9) | 4 (5.6) | 67 (94.4) | |||
| Unknown | 0 (0) | 9 (100.0) | 0 (0) | 9 (100.0) | |||
| Genomic subgroup | 0.284 | 0.165 | |||||
| IM | 2 (11.1) | 16 (88.9) | 1 (5.6) | 17 (94.4) | |||
| LAR | 4 (23.5) | 13 (76.5) | 2 (11.8) | 15 (88.2) | |||
| MES | 4 (11.1) | 32 (88.9) | 2 (5.6) | 34 (94.4) | |||
| BLIS | 10 (26.3) | 28 (73.7) | 8 (21.1) | 30 (78.9) | |||
| Genomic subgroup | 0.116 | 0.032* | |||||
| Non-BLIS | 10 (14.1) | 61 (85.9) | 5 (7.0) | 66 (93.0) | |||
| BLIS | 10 (26.3) | 28 (73.7) | 8 (21.1) | 30 (78.9) | |||
* indicates statistical significance.